After analyzing asample of 55 AD patients and 55 controls, they found thatAPOE4 was more frequent among the AD patients (20.9%versus 8.9%; p=0.038), establishing that one APOE ε4 allelewas enough to increase by 2.63 times the odds of being diagnosed withdementia. This evidence concerns the gene APOE and Alzheimer disease.